Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice.

by Dong Kyu Oh, Won Jun Ji, Woo Sung Kim, Chang-Min Choi, Shin-Kyo Yoon, Jin Kyung Rho, Jae Cheol Lee
Published 2019-01-01